Tibet Weixinkang Medicine Co., Ltd. (603676.SS)
CNY 10.79
(0.47%)
CNY 10.79
(0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.32 Billion | 1.39 Billion | 1.03 Billion | 715.66 Million | 740.96 Million | 746.32 Million |
| Cost of Revenue | 650.54 Million | 662.87 Million | 500.4 Million | 384.11 Million | 393.62 Million | 400.14 Million |
| Gross Profit | 672.1 Million | 735.66 Million | 533.22 Million | 331.55 Million | 347.34 Million | 346.18 Million |
| Operating Expenses | 497.13 Million | 568.48 Million | 435.83 Million | 286.22 Million | 302.59 Million | 290.41 Million |
| Selling, General and Administrative Expenses | 297.67 Million | 386.33 Million | 316.56 Million | 204.73 Million | 213.44 Million | 213.26 Million |
| Research and Development Expenses | 112.81 Million | 72.45 Million | 38.01 Million | 23.19 Million | 29.13 Million | 24.44 Million |
| Other Expenses | 40.87 Million | 109.69 Million | 81.25 Million | 58.29 Million | 60 Million | 1.09 Million |
| Cost and Expenses | 1.14 Billion | 1.23 Billion | 936.23 Million | 670.34 Million | 696.21 Million | 690.56 Million |
| Operating Income | 174.96 Million | 162.6 Million | 102.28 Million | 44.66 Million | 55.22 Million | 76.64 Million |
| Interest Expense | 342.28 Thousand | 189.51 Thousand | 114.8 Thousand | 1.29 Million | - | 523.51 Thousand |
| Income Tax Expense | 1.82 Million | 5.39 Million | 18.31 Million | 11.19 Million | 10.25 Million | 4.3 Million |
| Earnings before Tax | 215.83 Million | 182.35 Million | 114.22 Million | 69.62 Million | 65.93 Million | 77.74 Million |
| Net Income | 214.01 Million | 176.95 Million | 95.91 Million | 58.42 Million | 55.67 Million | 73.43 Million |
| Earnings Per Share Basic | 0.50 | 0.41 | 0.23 | 0.14 | 0.13 | 0.17 |
| Earnings Per Share Diluted | 0.50 | 0.41 | 0.23 | 0.14 | 0.13 | 0.17 |
| Weighted Average Shares Outstanding | 428.03 Million | 429.1 Million | 423 Million | 423 Million | 423 Million | 423 Million |
| Weighted Average Shares Outstanding (Diluted) | 428.03 Million | 429.1 Million | 423 Million | 423 Million | 423 Million | 431.97 Million |
| Gross Margin | 0.51 | 0.53 | 0.52 | 0.46 | 0.47 | 0.46 |
| EBIT Margin | 0.20 | 0.18 | 0.15 | 0.11 | 0.10 | 0.15 |
| Profit Margin | 0.16 | 0.13 | 0.09 | 0.08 | 0.08 | 0.10 |
| EBITDA | 266.6 Million | 225.68 Million | 152.43 Million | 68.51 Million | 94.16 Million | 100.9 Million |
| Earnings Before Tax Margin | 0.13 | 0.12 | 0.10 | 0.06 | 0.07 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 361.12 Million | 312.14 Million | 317.83 Million | 261.47 Million | 1.32 Billion | 311.76 Million |
| Cost of Revenue | 159.7 Million | 156.61 Million | 143.93 Million | 121.1 Million | 650.54 Million | 161.42 Million |
| Gross Profit | 201.41 Million | 155.53 Million | 173.9 Million | 140.36 Million | 672.1 Million | 150.34 Million |
| Operating Expenses | 114.87 Million | 97.14 Million | 110.86 Million | 162.86 Million | 526.66 Million | 116.53 Million |
| Selling, General and Administrative Expenses | 148.27 Million | 76.97 Million | 83.47 Million | 12.39 Million | - | 131.13 Million |
| Research and Development Expenses | 26.52 Million | 20.24 Million | 25.92 Million | 42.65 Million | - | 28.48 Million |
| Other Expenses | -59.92 Million | 81.13 Thousand | 41.48 Million | -418.28 Thousand | 40.87 Million | 40.99 Million |
| Cost and Expenses | 274.58 Million | 253.75 Million | 254.79 Million | 283.97 Million | 1.17 Billion | 277.96 Million |
| Operating Income | 89.52 Million | 58.39 Million | 65.09 Million | -2.14 Million | 174.96 Million | 37.67 Million |
| Interest Expense | 46.4 Thousand | 63.39 Thousand | 84.83 Thousand | 66.81 Thousand | 342.28 Thousand | 98.59 Thousand |
| Income Tax Expense | 8.97 Million | 6.24 Million | 11.66 Million | -6.33 Million | 1.82 Million | 2.43 Million |
| Earnings before Tax | 88.77 Million | 74.79 Million | 106.58 Million | -2.56 Million | 215.83 Million | 78.67 Million |
| Net Income | 79.8 Million | 68.54 Million | 94.91 Million | 3.77 Million | 214.01 Million | 76.23 Million |
| Earnings Per Share Basic | 0.18 | 0.16 | 0.22 | 0.01 | - | 0.18 |
| Earnings Per Share Diluted | 0.18 | 0.16 | 0.22 | 0.01 | - | 0.18 |
| Weighted Average Shares Outstanding | 435.16 Million | 431.62 Million | 431.43 Million | 424.98 Million | 428.03 Million | 423.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 435.16 Million | 431.62 Million | 431.43 Million | 424.94 Million | 428.03 Million | 423.55 Million |
| Gross Margin | 0.56 | 0.50 | 0.55 | 0.54 | 0.51 | 0.48 |
| EBIT Margin | 0.25 | 0.23 | 0.34 | -0.07 | - | 0.25 |
| Profit Margin | 0.22 | 0.22 | 0.30 | 0.01 | 0.16 | 0.24 |
| EBITDA | 88.82 Million | 71.84 Million | 108.56 Million | -17.98 Million | - | 78.52 Million |
| Earnings Before Tax Margin | 0.25 | 0.19 | 0.20 | -0.01 | 0.13 | 0.12 |
4758
000978
FNAUF
300222
3462
103590